1 terminated, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow BY101298 Capsules: new trials by email Literature Review of BY101298 Capsules trials Research Report on BY101298 Capsules
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid Tumors BY101298 Capsules, palliative radiotherapy, curative radiotherapy - Solid Tumor, Adult | Phase 1 / Phase 2 | Terminated | Chengdu Baiyu Pharmaceutical Co., Ltd. | 60 | 2024-05-15 | 2024-12-18 |
| A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors BY101298 Capsules - Solid Tumor, Adult | Phase 1 | Unknown | Chengdu Baiyu Pharmaceutical Co., Ltd. | 36 | 2023-04-25 | 2025-04-13 |
Chengdu Baiyu Pharmaceutical Co., Ltd. (2)
China (2)